EZH2 and diffuse large B-cell lymphoma: Their results also revealed that GSK126 effectively inhibited the proliferation of EZH2-mutant diffuse large B-cell lymphoma (DLBCL) cell lines and retarded the growth of EZH2-mutant DLBCL xenografts in mice (41).